CXA-10

Generic Name: CXA-10

Brand Names: -

Drug Type: Small Molecule

Chemical Formula: C_₁₈H_₃₃NO_₄

CAS Number: 875685-46-4

Unique Ingredient Identifier: 1N19AGY57Y

Background: CXA-10 is under investigation in clinical trial NCT03422510 (FIRSTx - A Study of Oral CXA-10 in Primary Focal Segmental Glomerulosclerosis (FSGS)).

Associated Conditions: -

Associated Therapies: -

Clinical Trials

Anti Inflammatory Lipid Mediators in Asthma Lipid Anti-Inflammtory Mediators in Asthma

Phase 2

Recruiting

Conditions: Obesity
Asthma

Interventions: Drug: Matching Placebo
Drug: CXA-10

First Posted Date: 2018-12-03

Last Posted Date: 2024-03-04

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 60

Registration Number: NCT03762395

Locations: 🇺🇸
University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States

Prev
1
Next

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy